Made Scientific
Private Company
Funding information not available
Overview
Made Scientific is a specialized CDMO in the high-growth cell and gene therapy sector, offering comprehensive development and manufacturing services. It differentiates itself through flexible partnership models, including traditional CDMO services, hybrid client-in-plant operations, and custom build-outs, supported by a focus on workforce development and training. As part of GC Corporation, it leverages corporate backing to provide integrated solutions aimed at accelerating client therapies to market.
Technology Platform
Cell therapy CDMO platform featuring AI Robotic Automation, end-to-end process & analytical development, GMP/non-GMP manufacturing, aseptic fill/finish, and hybrid client-in-plant operational models for T Cells, NK Cells, HSCs, MSCs, iPSCs, and TILs.
Opportunities
Risk Factors
Competitive Landscape
Operates in a highly competitive cell therapy CDMO sector competing against large multinationals (e.g., Lonza, Catalent) and specialized peers. Differentiation is sought through flexible partnership models, a focus on automation, and integrated workforce training programs.